Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Differential cytokine secretion results from p65 and c-Rel NF-κB subunit signaling in peripheral blood mononuclear cells of TNF receptor-associated periodic syndrome patients.

Nedjai B, Hitman GA, Church LD, Minden K, Whiteford ML, McKee S, Stjernberg S, Pettersson T, Ranki A, Hawkins PN, Arkwright PD, McDermott MF, Turner MD.

Cell Immunol. 2011;268(2):55-9. doi: 10.1016/j.cellimm.2011.02.007. Epub 2011 Mar 1.

PMID:
21420073
2.

Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome.

Nedjai B, Hitman GA, Quillinan N, Coughlan RJ, Church L, McDermott MF, Turner MD.

Arthritis Rheum. 2009 Feb;60(2):619-25. doi: 10.1002/art.24294.

3.

Candidate genes in patients with autoinflammatory syndrome resembling tumor necrosis factor receptor-associated periodic syndrome without mutations in the TNFRSF1A gene.

Borghini S, Fiore M, Di Duca M, Caroli F, Finetti M, Santamaria G, Ferlito F, Bua F, Picco P, Obici L, Martini A, Gattorno M, Ceccherini I.

J Rheumatol. 2011 Jul;38(7):1378-84. doi: 10.3899/jrheum.101260. Epub 2011 Apr 1.

PMID:
21459945
4.

Abnormal tumor necrosis factor receptor I cell surface expression and NF-kappaB activation in tumor necrosis factor receptor-associated periodic syndrome.

Nedjai B, Hitman GA, Yousaf N, Chernajovsky Y, Stjernberg-Salmela S, Pettersson T, Ranki A, Hawkins PN, Arkwright PD, McDermott MF, Turner MD.

Arthritis Rheum. 2008 Jan;58(1):273-83. doi: 10.1002/art.23123.

5.

The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway.

Greco E, Aita A, Galozzi P, Gava A, Sfriso P, Negm OH, Tighe P, Caso F, Navaglia F, Dazzo E, De Bortoli M, Rampazzo A, Obici L, Donadei S, Merlini G, Plebani M, Todd I, Basso D, Punzi L.

Arthritis Res Ther. 2015 Apr 3;17:93. doi: 10.1186/s13075-015-0604-7.

6.

PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit.

Jang HD, Yoon K, Shin YJ, Kim J, Lee SY.

J Biol Chem. 2004 Jun 4;279(23):24873-80. Epub 2004 Mar 26.

8.

Tumour necrosis factor receptor trafficking dysfunction opens the TRAPS door to pro-inflammatory cytokine secretion.

Turner MD, Chaudhry A, Nedjai B.

Biosci Rep. 2012 Apr 1;32(2):105-12. doi: 10.1042/BSR20110089. Review.

9.

NF-κB p65 and c-Rel subunits promote phagocytosis and cytokine secretion by splenic macrophages in cirrhotic patients with hypersplenism.

Ren S, Zhang S, Li M, Huang C, Liang R, Jiang A, Guo Y, Pu Y, Huang N, Yang J, Li Z.

Int J Biochem Cell Biol. 2013 Feb;45(2):335-43. doi: 10.1016/j.biocel.2012.11.012. Epub 2012 Nov 26.

PMID:
23195252
10.
12.

Temporal and subunit-specific modulations of the Rel/NF-kappaB transcription factors through CD28 costimulation.

Kahn-Perlès B, Lipcey C, Lécine P, Olive D, Imbert J.

J Biol Chem. 1997 Aug 29;272(35):21774-83.

13.

Systemic cytokine levels and the effects of etanercept in TNF receptor-associated periodic syndrome (TRAPS) involving a C33Y mutation in TNFRSF1A.

Nowlan ML, Drewe E, Bulsara H, Esposito N, Robins RA, Tighe PJ, Powell RJ, Todd I.

Rheumatology (Oxford). 2006 Jan;45(1):31-7. Epub 2005 Nov 15.

14.

Suppression of NF-kappaB-dependent proinflammatory gene expression in human RPE cells by a proteasome inhibitor.

Wang XC, Jobin C, Allen JB, Roberts WL, Jaffe GJ.

Invest Ophthalmol Vis Sci. 1999 Feb;40(2):477-86.

PMID:
9950608
15.

Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS).

Bachetti T, Chiesa S, Castagnola P, Bani D, Di Zanni E, Omenetti A, D'Osualdo A, Fraldi A, Ballabio A, Ravazzolo R, Martini A, Gattorno M, Ceccherini I.

Ann Rheum Dis. 2013 Jun;72(6):1044-52. doi: 10.1136/annrheumdis-2012-201952. Epub 2012 Oct 31.

PMID:
23117241
17.

A proximal kappaB site in the IL-23 p19 promoter is responsible for RelA- and c-Rel-dependent transcription.

Mise-Omata S, Kuroda E, Niikura J, Yamashita U, Obata Y, Doi TS.

J Immunol. 2007 Nov 15;179(10):6596-603.

18.

Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.

Jackson-Bernitsas DG, Ichikawa H, Takada Y, Myers JN, Lin XL, Darnay BG, Chaturvedi MM, Aggarwal BB.

Oncogene. 2007 Mar 1;26(10):1385-97. Epub 2006 Sep 4.

PMID:
16953224
20.

A novel TNFRSF1A splice mutation associated with increased nuclear factor kappaB (NF-kappaB) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS).

Churchman SM, Church LD, Savic S, Coulthard LR, Hayward B, Nedjai B, Turner MD, Mathews RJ, Baguley E, Hitman GA, Gooi HC, Wood PM, Emery P, McDermott MF.

Ann Rheum Dis. 2008 Nov;67(11):1589-95. Epub 2007 Dec 17.

PMID:
18086728
Items per page

Supplemental Content

Write to the Help Desk